MARKET

ADPT

ADPT

Adaptive Biotechnologies
NASDAQ
20.96
+0.71
+3.51%
After Hours: 21.17 +0.21 +0.98% 19:54 06/26 EDT
OPEN
20.08
PREV CLOSE
20.25
HIGH
21.01
LOW
19.96
VOLUME
6.47M
TURNOVER
--
52 WEEK HIGH
21.01
52 WEEK LOW
9.96
MARKET CAP
3.35B
P/E (TTM)
-64.0195
1D
5D
1M
3M
1Y
5Y
1D
Does Adaptive Biotechnologies’ (ADPT) Convertible Raise and Split Plan Reveal a New Strategic Center of Gravity?
Simply Wall St · 2d ago
Wednesday's ETF Movers: ARKG, SLVR
NASDAQ · 4d ago
KB Home Posts Upbeat Q2 Sales, Joins Inmode, Icon And Other Big Stocks Moving Higher On Wednesday
Benzinga · 4d ago
Adaptive Biotechnologies Issues Convertible Notes to Reshape Capital
TipRanks · 6d ago
ADAPTIVE BIOTECHNOLOGIES CORP - NET PROCEEDS FROM OFFERING ABOUT $334.5 MLN - SEC FILING
Reuters · 6d ago
ADAPTIVE BIOTECHNOLOGIES CORP - ISSUES $345 MLN IN 0% CONVERTIBLE SENIOR NOTES DUE 2031 - SEC FILING
Reuters · 6d ago
Adaptive Biotechnologies prices upsized USD 300 million 0% convertible senior notes offering due 2031
PUBT · 6d ago
Weekly Report: what happened at ADPT last week (0615-0619)?
Weekly Report · 06/22 09:09
More
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage company. The Company focuses on the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its technologies to read the genetic code of a patient's immune system. It operates through two segments, which include Minimal Residual Disease (MRD) and Immune Medicine. The MRD business focuses on the use of its sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. Its MRD business is comprised of its clonoSEQ clinical diagnostic testing service, offered to clinicians. Its Immune Medicine business focuses on immune-repertoire sequencing, target antigen discovery, data licensing and TCR-antigen prediction models in the identification, validation, development and adoption of products and services.

Webull offers Adaptive Biotechnologies Corp stock information, including NASDAQ: ADPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADPT stock methods without spending real money on the virtual paper trading platform.